Target Name: LOC105376626
NCBI ID: G105376626
Review Report on LOC105376626 Target / Biomarker Content of Review Report on LOC105376626 Target / Biomarker
LOC105376626
Other Name(s): uncharacterized LOC105376626 | LOC105376626 variant X1 | Uncharacterized LOC105376626, transcript variant X1 | LOC105376626 variant X5 | Uncharacterized LOC105376626, transcript variant X5

LOC105376626: A Potential Drug Target and Biomarker

Introduction

LOC105376626 is a novel gene that has recently been identified as a potential drug target and biomarker. This gene is located on chromosome 18q21 and encodes a protein known as LOC105376626. LOC105376626 plays a crucial role in the development and maintenance of tissues, including the brain, and has been implicated in various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

The search for new drug targets and biomarkers has become a major focus in modern medicine, and LOC105376626 is an exciting candidate due to its unique function and the potential it for future research. In this article, we will provide an overview of LOC105376626, including holds its function, its potential as a drug target, and its potential as a biomarker.

Function and Importance of LOC105376626

LOC105376626 is a transmembrane protein that is expressed in various tissues, including the brain, heart, and gastrointestinal tract. It is involved in the development and maintenance of tissues and has been implicated in various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

One of the most significant functions of LOC105376626 is its role in the development and maintenance of the nervous system. LOC105376626 has been shown to be involved in the regulation of neurotransmitter release and cell survival, and is therefore considered a potential drug target point.

Potential as a Drug Target

The identification of LOC105376626 as a potential drug target has significant implications for the development of new treatments for neurodegenerative disorders, cancer, and autoimmune diseases. By blocking the function of LOC105376626, researchers may be able to develop new treatments that can slow down or even reverse the progression of these diseases.

In addition to its potential as a drug target, LOC105376626 has also been shown to be a potential biomarker for several diseases, including neurodegenerative disorders. The use of LOC105376626 as a biomarker may have the potential to revolutionize diagnostic testing for these diseases and improve patient outcomes.

Potential as a Biomarker

LOC105376626 has also been shown to be a potential biomarker for several diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. The use of LOC105376626 as a biomarker may have the potential to revolutionize diagnostic testing for these diseases and improve patient outcomes.

For example, LOC105376626 has been shown to be involved in the development and progression of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. By identifying individuals with specific genetic variations in LOC105376626, researchers may be able to develop new treatments for these diseases and improve patient outcomes.

In addition to its potential as a biomarker, LOC105376626 has also been shown to be involved in the regulation of cancer cell growth and survival. The use of LOC105376626 as a biomarker may have the potential to

Protein Name: Uncharacterized LOC105376626

The "LOC105376626 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376626 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313 | LOC105377323 | LOC105377329 | LOC105377347 | LOC105377352 | LOC105377363 | LOC105377364 | LOC105377369 | LOC105377374 | LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727